Varian forms global council for RapidArc growth:
This article was originally published in Clinica
As part of the ongoing development of its RapidArc radiotherapy system, Varian Medical Systems has formed a council of cancer centres in North America and Europe to explore further clinical applications of the technology. The council members will meet regularly with Varian's engineers in Switzerland, Finland and the US, to collaborate on future improvements to the system. RapidArc is a volumetric arc therapy system designed to deliver image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster than conventional IMRT or helical treatments. It was cleared by the US FDA in January (see Clinica No 1289, p 18) and first shipments of the product are expected to begin in April this year.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.